Loading…
TherapeuticsMD, Inc. is projected to rise to $2.13 by 2027, a +7% move from its current price of $2.00. TXMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.93 | $2.00 | $2.07 | +0.03% |
| Jul 14 | $1.90 | $2.00 | $2.10 | +0.06% |
| Jul 15 | $1.88 | $2.00 | $2.13 | +0.09% |
| Jul 16 | $1.86 | $2.00 | $2.15 | +0.12% |
| Jul 17 | $1.85 | $2.00 | $2.17 | +0.15% |
| Jul 18 | $1.84 | $2.00 | $2.19 | +0.18% |
| Jul 19 | $1.82 | $2.00 | $2.20 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.82 | $2.00 | $2.20 | +0.21% |
| Week 2 | $1.76 | $2.01 | $2.29 | +0.42% |
| Week 3 | $1.71 | $2.01 | $2.37 | +0.63% |
| Week 4 | $1.67 | $2.02 | $2.43 | +0.84% |
| Week 5 | $1.64 | $2.02 | $2.49 | +1.05% |
| Week 6 | $1.61 | $2.03 | $2.55 | +1.27% |
| Week 7 | $1.58 | $2.03 | $2.60 | +1.48% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its product portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system.
The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors.
TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
TXMD trades at $2.11 per share, with a market cap of $24.42M, and an overall rank of 4806.
A major floor 21.7% below — a decisive break under it would weaken the trend.
The nearest floor, 9.0% below — buyers have tended to step in here.
The nearest ceiling, 14.5% above — a clean break opens room to run.
A major ceiling 25.3% above — clearing it would confirm fresh momentum.
Key TXMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TXMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.98 | Buy | $2.01 | Sell |
| MA 10 | $2.08 | Sell | $2.04 | Sell |
| MA 20 | $2.08 | Sell | $2.05 | Sell |
| MA 50 | $2.05 | Sell | $2.06 | Sell |
| MA 100 | $2.12 | Sell | $2.04 | Sell |
| MA 200 | $1.89 | Buy | $1.91 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.04 | Neutral |
| Stoch RSI (14) | 13.64 | Buy |
| CCI (20) | -46.38 | Neutral |
| Williams %R (14) | -88.89 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.35 | Neutral |
| Stochastic %K (14) | 11.11 | Buy |
| TRIX (15) | 0.03 | Buy |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 29.93 | Buy |
| Momentum (10) | -0.03 | Sell |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 1.94 | Buy |
| ADX (14) | 13.31 | Neutral |
| ATR (14) | 0.05 | Info |
The 14-day RSI sits at 50, indicating a neutral short-term momentum. The stock is trading near its moving averages, with SMA50 at $2.06 and SMA200 at $1.84.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.65 | $2.00 | $2.73 | 0% | Neutral | |
| $1.65 | $2.13 | $2.94 | +7% | Neutral | |
| $2.03 | $2.73 | $3.94 | +36% | Bullish | |
| $2.37 | $3.29 | $4.92 | +64% | Bullish | |
| $2.61 | $3.72 | $5.74 | +86% | Bullish | |
| $2.62 | $3.82 | $6.05 | +91% | Bullish | |
| $2.51 | $3.75 | $6.08 | +88% | Bullish | |
| $2.64 | $4.03 | $6.68 | +102% | Bullish | |
| $2.66 | $4.15 | $7.01 | +108% | Bullish | |
| $3.08 | $4.92 | $8.46 | +146% | Bullish | |
| $3.57 | $6.28 | $11.61 | +214% | Bullish | |
| $6.98 | $14.62 | $30.06 | +631% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.65 | $2.00 | $2.48 | +0.00% |
| August 2026 | $1.78 | $2.11 | $2.59 | +5.65% |
| September 2026 | $1.71 | $2.06 | $2.56 | -2.72% |
| October 2026 | $1.72 | $2.08 | $2.62 | +1.04% |
| November 2026 | $1.78 | $2.17 | $2.76 | +4.31% |
| December 2026 | $1.74 | $2.13 | $2.73 | -1.75% |
Click any year to see its month-by-month TXMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, TXMD could reach as high as $2.73, with a base case around $2.00 and support toward $1.65 — roughly 0% from $2.00. Price action looks broadly range-bound.
Expect TXMD to range from $1.65 to $2.94 through 2027. The $2.13 average target implies a +7% move from current prices. That is up +7% on the projected 2026 average. A consolidation phase looks the most probable path here.
The TXMD price prediction for 2028 points to an average of $2.73 (low $2.03, high $3.94) — a potential gain of +36% on today's $2.00. Momentum favours further upside here.
In 2029, TXMD is projected to trade between $2.37 and $4.92, averaging $3.29 — a potential gain of +64% from today's $2.00. That is up +21% on the projected 2028 average. Buyers look set to stay in control over this stretch.
TherapeuticsMD, Inc.'s 2030 outlook centres on $3.72, within a $2.61 to $5.74 range. That is up +13% on the projected 2029 average. That marks a +86% change versus current levels. Momentum favours further upside here.
By 2031, TXMD could reach as high as $6.05, with a base case around $3.82 and support toward $2.62 — roughly +91% from $2.00. Buyers look set to stay in control over this stretch.
Expect TXMD to range from $2.51 to $6.08 through 2032. The $3.75 average target implies a +88% move from current prices. That is -2% versus the projected 2031 average. Momentum favours further upside here.
The TXMD price prediction for 2033 points to an average of $4.03 (low $2.64, high $6.68) — a potential gain of +102% on today's $2.00. Buyers look set to stay in control over this stretch.
In 2034, TXMD is projected to trade between $2.66 and $7.01, averaging $4.15 — a potential gain of +108% from today's $2.00. That is up +3% on the projected 2033 average. Momentum favours further upside here.
TherapeuticsMD, Inc.'s 2035 outlook centres on $4.92, within a $3.08 to $8.46 range. That is up +19% on the projected 2034 average. That marks a +146% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, TXMD could reach as high as $11.61, with a base case around $6.28 and support toward $3.57 — roughly +214% from $2.00. Momentum favours further upside here.
Expect TXMD to range from $6.98 to $30.06 through 2050. The $14.62 average target implies a +631% move from current prices. That is up +133% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in TXMD today (≈ 500 TXMD) could be worth
$7,308.35
+$6,308.35 (+631%) by 2050 · US Dollar
Based on the average projected TXMD price of $14.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TXMDwould be worth at today's price.
$1,000 invested in TXMD on Jul 10, 2025 (≈ 833.3333 TXMD) would be worth
$1,666.67
+$666.67 (+66.7%) today · 1.67× · US Dollar
Based on a TXMD entry price of $1.2 vs. today's $2.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.11 | $947.87 | -5.2% |
| 1 month ago | $1.86 | $1,075.27 | +7.5% |
| 3 months ago | $2.07 | $966.18 | -3.4% |
| 6 months ago | $2.08 | $961.54 | -3.8% |
| 1 year ago | $1.2 | $1,666.67 | +66.7% |
| All time (5.0y) ago | $53.5 | $37.38 | -96.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TXMD forecast.
Our base-case forecast reaches $4.00 around 2033.
Implied market cap at $4.00: $46.3M
The multi-year forecast shows a bullish trajectory, with the 2026 avg price at $2.11 and the 2050 avg price at $14.35. The forecast also lists 2028 avg $2.91, 2030 avg $3.94, and 2040 avg $6.21, culminating in a 2050 max of $31.75. Projected ROIs rise from 0% in 2026 to 580% by 2050, with notable steps such as 38% in 2028, 61.3% in 2029, and 86.8% in 2030.
The outlook suggests meaningful upside across the horizon, but these are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $3.94; min $2.65; max $6.35; ROI 86.8%. (2026 min $1.65, avg $2.11, max $2.85; 2027 min $1.66, avg $2.20, max $3.13; 2028 min $2.10, avg $2.91, max $4.36; 2029 min $2.37, avg $3.40, max $5.30).
Forecasts show a bullish path from 2028 onward, with 2028 avg $2.91 and 2050 avg $14.35, and a 2050 max of $31.75. The ROI rises to 580% by 2050, reflecting potential upside, though these figures are estimates and not guarantees.
Yes. The max forecast by 2050 is $31.75.
$1.60 to $2.78.
Current price is $2.11 and market cap is $24.42M.
TherapeuticsMD, Inc. Community Discussion
0Share your TherapeuticsMD, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.